Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Ret Proto-Oncogene Antikörper (pTyr1062)

Der Kaninchen Polyklonal anti-Ret Proto-Oncogene Antikörper wird verwendet zum Nachweis von Ret Proto-Oncogene in Proben von Human. Er wurde validiert für WB, ELISA, IF (p), IF (cc), IHC (p) und IHC (fro).
Produktnummer ABIN745538
357,70 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μL
Lieferung nach: Deutschland
Lieferung in 8 bis 12 Werktagen

Kurzübersicht für Ret Proto-Oncogene Antikörper (pTyr1062) (ABIN745538)

Target

Alle Ret Proto-Oncogene (RET) Antikörper anzeigen
Ret Proto-Oncogene (RET)

Reaktivität

  • 230
  • 110
  • 84
  • 5
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Human

Wirt

  • 191
  • 90
  • 2
  • 2
  • 1
Kaninchen

Klonalität

  • 177
  • 109
Polyklonal

Konjugat

  • 144
  • 16
  • 11
  • 9
  • 6
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Dieser Ret Proto-Oncogene Antikörper ist unkonjugiert

Applikation

  • 184
  • 92
  • 87
  • 65
  • 65
  • 46
  • 28
  • 27
  • 21
  • 17
  • 14
  • 10
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
Western Blotting (WB), ELISA, Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunofluorescence (Cultured Cells) (IF (cc)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))
  • Bindungsspezifität

    • 66
    • 20
    • 18
    • 15
    • 15
    • 15
    • 12
    • 9
    • 9
    • 9
    • 8
    • 8
    • 8
    • 8
    • 4
    • 4
    • 4
    • 4
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    pTyr1062

    Homologie

    Human,Mouse,Rat,Dog,Cow,Rabbit

    Aufreinigung

    Purified by Protein A.

    Immunogen

    KLH conjugated synthetic phosphopeptide derived from human Ret around the phosphorylation site of Tyr1062

    Isotyp

    IgG
  • Applikationshinweise

    WB 1:300-5000
    ELISA 1:500-1000
    IHC-P 1:200-400
    IHC-F 1:100-500
    IF(IHC-P) 1:50-200
    IF(IHC-F) 1:50-200
    IF(ICC) 1:50-200

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    1 μg/μL

    Buffer

    0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.

    Konservierungsmittel

    ProClin

    Vorsichtsmaßnahmen

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.

    Haltbarkeit

    12 months
  • Target

    Ret Proto-Oncogene (RET)

    Andere Bezeichnung

    Ret

    Hintergrund

    Synonyms: C ret, Cadherin family member 12, Cadherin related family member 16, CDHF 12, CDHF12, CDHR16, ELKS Fusion gene, HSCR 1, HSCR1, Hydroxyaryl protein kinase, MEN2A, MEN2B, MTC 1, MTC1, Multiple endocrine neoplasia and medullary thyroid carcinoma 1, Oncogene RET, Proto oncogene tyrosine protein kinase receptor ret, Proto-oncogene c-Ret, Proto-oncogene tyrosine-protein kinase receptor ret, PTC, RET, RET ELE1, Ret Proto oncogene, RET transforming sequence, RET_HUMAN, RET51, RET9, tyrosine-protein kinase receptor ret.

    Background: The CD4 antigen is highly expressed on human T helper cells and thymocytes, and at lower levels on monocytes and dendritic cells. This integral membrane glycoprotein of approximately 58 kDa contains four external domains (D1 to D4) that show homology to members of the immunoglobulin (Ig) superfamily. It is responsible for the recognition of the MHC class II antigen. The CD4 antibody recognizes most thymocytes and about 65 % of peripheral blood T cells.

    Gen-ID

    5979

    Pathways

    RTK Signalweg, Dopaminergic Neurogenesis, Regulation of Cell Size, Tube Formation
Sie sind hier:
Chat with us!